The trajectory of the erectile dysfunction drug presents a intricate picture for investors. While the initial introduction generated substantial profits, the lapse of its exclusive rights opened the avenue to generic https://cruxbookmarks.com/story21721797/the-copyright-and-big-pharma-a-volatile-investment